Screener
Royalty Pharma RPRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on trailing twelve months.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's operating margin?
- Royalty Pharma (RPRX) reported operating margin of 59.6% in Q2 2026.
- How has Royalty Pharma's operating margin changed year-over-year?
- Royalty Pharma's operating margin decreased by 25.3% year-over-year, from 79.8% to 59.6%.
- What is the long-term trend for Royalty Pharma's operating margin?
- Over 4 years (2020 to 2025), Royalty Pharma's operating margin has grown at a -3.4% compound annual growth rate (CAGR), from 75.2% to 65.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Royalty Pharma's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude